Author

Kim Lucia Schneider

Universitätsmedizin Göttingen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Bettina Mundt· 1 shared Bjoern PapkeiD· 1 shared Florian KühneliD· 1 shared Florian WegwitziD· 1 shared Friedrich FeuerhakeiD· 1 shared Lena‐Christin ConradiiD· 1 shared Ramona Schulz‐HeddergottiD· 1 shared Sebastian StintzingiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bettina Mundt

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition

Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz, Tiago De Oliveira, Lena‐Christin Conradi, Valery Volk, Friedrich Feuerhake, Bjoern Papke, Sebastian Stintzing, Bettina Mundt, Florian Kühnel, Ute Martha Moll, Ramona Schulz‐Heddergott

This study shows that combining HSP90 inhibitors with p53 activation or CDK4/6 inhibition enhances colorectal cancer therapy by disrupting the HSF1-HSR feedback loop.

Cell Death and Differentiation · Apr 9, 2025Peer-reviewedCancer Biology